- Home
- CELC vs VSCO Comparison
CELC vs VSCO Comparison
Compare CELC & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | VSCO |
|---|---|---|
| Founded | 2011 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.4B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CELC | VSCO |
|---|---|---|
| Price | $114.71 | $48.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $107.88 | $54.55 |
| AVG Volume (30 Days) | 646.7K | ★ 2.4M |
| Earning Date | 05-13-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.93 |
| Revenue | N/A | ★ $6,553,000,000.00 |
| Revenue This Year | N/A | $9.22 |
| Revenue Next Year | $706.83 | $2.81 |
| P/E Ratio | ★ N/A | $25.00 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $7.61 | $15.34 |
| 52 Week High | $120.32 | $66.89 |
Technical Indicators
Market Signals| Indicator | CELC | VSCO |
|---|---|---|
| Relative Strength Index (RSI) | 55.64 | 49.21 |
| Support Level | $99.38 | $43.05 |
| Resistance Level | $117.61 | $49.11 |
| Average True Range (ATR) | 6.16 | 2.48 |
| MACD | 0.41 | 0.86 |
| Stochastic Oscillator | 80.51 | 84.14 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels. The Company also includes the merchandise sourcing and production function serving the Company and its international partners.